Nifty IT Bottoming? Anand James Bullish on SURYAINDIA, CHOLAFIN

Anand James from Geojit Investments has provided a market outlook for the upcoming expiry week, predicting a Nifty breakout above 23,700. He specifically pointed to early signs of a bottom in the Nifty IT index and warned of potential profit booking in the Pharma sector. Additionally, he recommended Surya Roshni and Cholamandalam Investment for short-term trading.

This analysis is crucial for traders as it offers specific directional cues for the broader market (Nifty), identifies potential sector rotations (IT recovery, Pharma correction), and provides actionable stock-specific recommendations. The Nifty breakout target suggests potential for overall market upside, while sector-specific warnings help manage risk and identify opportunities.

The Nifty IT index, including major players like TCS, Infosys, Wipro, and HCL Tech, could see positive momentum if the bottoming out trend confirms. Conversely, Pharma stocks such as Sun Pharma, Dr. Reddy's, Cipla, and Divi's Lab might experience selling pressure due to anticipated profit booking. Surya Roshni (SURYAINDIA) and Cholamandalam Investment (CHOLAFIN) are highlighted for potential short-term gains.

Traders should closely monitor Nifty's movement around the 23,700 level for a confirmed breakout. For Nifty IT, look for sustained upward momentum and volume confirmation. In Pharma, observe price action for signs of profit booking materializing. For the recommended stocks, watch for entry points and set appropriate stop-losses based on technical analysis.

• •Anand James expects Nifty to attempt a range breakout above 23,700 during the monthly expiry week.
• •He highlighted early bottoming signs in the Nifty IT index.
• •He warned of near-term profit booking in Pharma stocks.
• •He shared bullish technical views on Surya Roshni and Cholamandalam Investment for short-term trading opportunities.
• •Risk flag: Regulatory changes (e.g., USFDA actions)